Lilly’s Obesity Pill Will Have Far-Reaching Effect, Doctors Say

Lilly’s Obesity Pill Will Have Far-Reaching Effect, Doctors Say

Eli Lilly & Co.’s obesity pill prompted enough weight loss in a large clinical trial to be meaningful for patients and have far-reaching implications for the field, doctors said.

Novel GLP-1 Pill for Obesity Passes Phase III Test

(MedPage Today) — An investigational small-molecule, nonpeptide oral GLP-1 receptor agonist significantly reduced weight in adults with obesity in the randomized ATTAIN-1 trial. At week 72, orforglipron at multiple doses proved superior to placebo… Source link : https://www.medpagetoday.com/meetingcoverage/easd/117495 Author : Publish date : 2025-09-16 22:01:00 Copyright for syndicated content belongs to the linked Source. The post Novel GLP-1 P…